These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

472 related items for PubMed ID: 17478621

  • 1. Muscle atrophy and hypertrophy signaling in patients with chronic obstructive pulmonary disease.
    Doucet M, Russell AP, Léger B, Debigaré R, Joanisse DR, Caron MA, LeBlanc P, Maltais F.
    Am J Respir Crit Care Med; 2007 Aug 01; 176(3):261-9. PubMed ID: 17478621
    [Abstract] [Full Text] [Related]

  • 2. Atrogin-1, MuRF1, and FoXO, as well as phosphorylated GSK-3beta and 4E-BP1 are reduced in skeletal muscle of chronic spinal cord-injured patients.
    Léger B, Senese R, Al-Khodairy AW, Dériaz O, Gobelet C, Giacobino JP, Russell AP.
    Muscle Nerve; 2009 Jul 01; 40(1):69-78. PubMed ID: 19533653
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Human skeletal muscle atrophy in amyotrophic lateral sclerosis reveals a reduction in Akt and an increase in atrogin-1.
    Léger B, Vergani L, Sorarù G, Hespel P, Derave W, Gobelet C, D'Ascenzio C, Angelini C, Russell AP.
    FASEB J; 2006 Mar 01; 20(3):583-5. PubMed ID: 16507768
    [Abstract] [Full Text] [Related]

  • 6. MuRF-1 and atrogin-1 protein expression and quadriceps fiber size and muscle mass in stable patients with COPD.
    Natanek SA, Riddoch-Contreras J, Marsh GS, Hopkinson NS, Moxham J, Man WD, Kemp PR, Polkey MI.
    COPD; 2013 Oct 01; 10(5):618-24. PubMed ID: 23844868
    [Abstract] [Full Text] [Related]

  • 7. Suppression of atrogin-1 and MuRF1 prevents dexamethasone-induced atrophy of cultured myotubes.
    Castillero E, Alamdari N, Lecker SH, Hasselgren PO.
    Metabolism; 2013 Oct 01; 62(10):1495-502. PubMed ID: 23866982
    [Abstract] [Full Text] [Related]

  • 8. IGF-I does not prevent myotube atrophy caused by proinflammatory cytokines despite activation of Akt/Foxo and GSK-3beta pathways and inhibition of atrogin-1 mRNA.
    Dehoux M, Gobier C, Lause P, Bertrand L, Ketelslegers JM, Thissen JP.
    Am J Physiol Endocrinol Metab; 2007 Jan 01; 292(1):E145-50. PubMed ID: 16926385
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. MAPK signaling in the quadriceps of patients with chronic obstructive pulmonary disease.
    Lemire BB, Debigaré R, Dubé A, Thériault ME, Côté CH, Maltais F.
    J Appl Physiol (1985); 2012 Jul 01; 113(1):159-66. PubMed ID: 22518834
    [Abstract] [Full Text] [Related]

  • 11. Influence of divergent exercise contraction mode and whey protein supplementation on atrogin-1, MuRF1, and FOXO1/3A in human skeletal muscle.
    Stefanetti RJ, Lamon S, Rahbek SK, Farup J, Zacharewicz E, Wallace MA, Vendelbo MH, Russell AP, Vissing K.
    J Appl Physiol (1985); 2014 Jun 01; 116(11):1491-502. PubMed ID: 24458747
    [Abstract] [Full Text] [Related]

  • 12. Glycogen synthase kinase-3β is required for the induction of skeletal muscle atrophy.
    Verhees KJ, Schols AM, Kelders MC, Op den Kamp CM, van der Velden JL, Langen RC.
    Am J Physiol Cell Physiol; 2011 Nov 01; 301(5):C995-C1007. PubMed ID: 21832246
    [Abstract] [Full Text] [Related]

  • 13. Ubiquitin E3 ligase Atrogin-1 protein is regulated via the rapamycin-sensitive mTOR-S6K1 signaling pathway in C2C12 muscle cells.
    Nishimura Y, Chunthorng-Orn J, Lord S, Musa I, Dawson P, Holm L, Lai YC.
    Am J Physiol Cell Physiol; 2022 Jul 01; 323(1):C215-C225. PubMed ID: 35704697
    [Abstract] [Full Text] [Related]

  • 14. mTORC1 promotes denervation-induced muscle atrophy through a mechanism involving the activation of FoxO and E3 ubiquitin ligases.
    Tang H, Inoki K, Lee M, Wright E, Khuong A, Khuong A, Sugiarto S, Garner M, Paik J, DePinho RA, Goldman D, Guan KL, Shrager JB.
    Sci Signal; 2014 Feb 25; 7(314):ra18. PubMed ID: 24570486
    [Abstract] [Full Text] [Related]

  • 15. Deficiency of inducible nitric oxide synthase attenuates immobilization-induced skeletal muscle atrophy in mice.
    Bae SK, Cha HN, Ju TJ, Kim YW, Kim HS, Kim YD, Dan JM, Kim JY, Kim SD, Park SY.
    J Appl Physiol (1985); 2012 Jul 25; 113(1):114-23. PubMed ID: 22518831
    [Abstract] [Full Text] [Related]

  • 16. Excessive glucocorticoid-induced muscle MuRF1 overexpression is independent of Akt/FoXO1 pathway.
    Wang XJ, Xiao JJ, Liu L, Jiao HC, Lin H.
    Biosci Rep; 2017 Dec 22; 37(6):. PubMed ID: 29046370
    [Abstract] [Full Text] [Related]

  • 17. The IGF-1/PI3K/Akt pathway prevents expression of muscle atrophy-induced ubiquitin ligases by inhibiting FOXO transcription factors.
    Stitt TN, Drujan D, Clarke BA, Panaro F, Timofeyva Y, Kline WO, Gonzalez M, Yancopoulos GD, Glass DJ.
    Mol Cell; 2004 May 07; 14(3):395-403. PubMed ID: 15125842
    [Abstract] [Full Text] [Related]

  • 18. IGF-1 prevents ANG II-induced skeletal muscle atrophy via Akt- and Foxo-dependent inhibition of the ubiquitin ligase atrogin-1 expression.
    Yoshida T, Semprun-Prieto L, Sukhanov S, Delafontaine P.
    Am J Physiol Heart Circ Physiol; 2010 May 07; 298(5):H1565-70. PubMed ID: 20228261
    [Abstract] [Full Text] [Related]

  • 19. Effects of 3 days unloading on molecular regulators of muscle size in humans.
    Gustafsson T, Osterlund T, Flanagan JN, von Waldén F, Trappe TA, Linnehan RM, Tesch PA.
    J Appl Physiol (1985); 2010 Sep 07; 109(3):721-7. PubMed ID: 20538844
    [Abstract] [Full Text] [Related]

  • 20. AMP-activated protein kinase enhances the expression of muscle-specific ubiquitin ligases despite its activation of IGF-1/Akt signaling in C2C12 myotubes.
    Tong JF, Yan X, Zhu MJ, Du M.
    J Cell Biochem; 2009 Oct 01; 108(2):458-68. PubMed ID: 19639604
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.